Zobrazeno 1 - 10
of 1 433
pro vyhledávání: '"de Hooge, A."'
Autor:
Hendrikus H. Boersma, Mirte M. Woerdenbag, Sascha Mulder, Tirza W. T. Poiesz, Lucas B. S. Bekhof, Hein T. Tholen, Gert Luurtsema, Marjolijn N. Lub-de Hooge, Danique Giesen, Herman J. Woerdenbag
Publikováno v:
Hygiene, Vol 4, Iss 3, Pp 282-296 (2024)
Environmental monitoring (EM) is the cornerstone for the assurance of sterility during aseptic manufacturing. In this study, the EM quality aspects in the radiopharmaceutical cleanrooms of the University Medical Center Groningen (UMCG), The Netherlan
Externí odkaz:
https://doaj.org/article/8ae27a52bf2c40e99b9f42bb72380081
Autor:
Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Roberta Ramonda, Alexandre Sepriano, Manouk de Hooge, Floris A van Gaalen, Karen Minde Fagerli, Sofia Exarchou, Caroline Bastiaenen, Miranda van Lunteren, Philipp Bosch, Mary-Lucy Marques, Liese de Bruin
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives To follow up four previously identified classes ‘pure axial spondyloarthritis’ (axSpA) (‘axial’), ‘axSpA with peripheral signs’ (‘inflammatory back pain+peripheral’), ‘axSpA at risk’ and ‘no spondyloarthritis’ (‘n
Externí odkaz:
https://doaj.org/article/e2082ad57e7d429cb128b1c8ea98a89a
Autor:
Linda N. Broer, Daan G. Knapen, Derk-Jan A. de Groot, Peter G.M. Mol, Jos G.W. Kosterink, Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge
Publikováno v:
iScience, Vol 27, Iss 6, Pp 110115- (2024)
Summary: Monoclonal antibodies are important cancer medicines. The European Medicines Agency (EMA) approved 48 and the Food and Drug Administration (FDA) 56 anticancer monoclonal antibody-based therapies. Their high prices burden healthcare systems a
Externí odkaz:
https://doaj.org/article/cbbec29fb32247bf84c0de6ad6bf2e14
Autor:
Robert Landewé, Kim Lauper, Theodora P M Vliet Vlieland, Uta Kiltz, Jette Primdahl, Ricardo J O Ferreira, Mwidimi Ndosi, Manouk de Hooge, Tue Wenzel Kragstrup, Souzi Makri, Luis Fernando Perez-Garcia, Elsa Frãzao-Mateus, Peter Boyd
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective European Alliance of Associations for Rheumatology (EULAR) task forces (TF) requires participation of ≥2 junior members, a health professional in rheumatology (HPR) and two patient research partners for the development of recommendations
Externí odkaz:
https://doaj.org/article/b2e4a247b98f4ea18ed858e122a54da4
Autor:
Broer, Linda N., Knapen, Daan G., de Groot, Derk-Jan A., Mol, Peter G.M., Kosterink, Jos G.W., de Vries, Elisabeth G.E., Lub-de Hooge, Marjolijn N.
Publikováno v:
In iScience 21 June 2024 27(6)
Autor:
Philipp Mohr, Joyce van Sluis, Marjolijn N. Lub-de Hooge, Adriaan A. Lammertsma, Adrienne H. Brouwers, Charalampos Tsoumpas
Publikováno v:
Frontiers in Nuclear Medicine, Vol 4 (2024)
Immuno-positron emission tomography (immunoPET) enables imaging of specific targets that play a role in targeted therapy and immunotherapy, such as antigens on cell membranes, targets in the disease microenvironment, or immune cells. The most common
Externí odkaz:
https://doaj.org/article/7d565d08171149268448b6d9f6bf195b
Autor:
Sofia Ramiro, Désirée van der Heijde, Monique Reijnierse, Torsten Diekhoff, Manouk de Hooge, Floris A van Gaalen, Mary Lucy Marques, Kay Geert A. Hermann
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Background: The Computed Tomography Syndesmophyte Score (CTSS) was developed as a reliable and sensitive tool to assess syndesmophytes in low-dose CT images of the entire spine in patients with axial spondyloarthritis (axSpA). The original paper prov
Externí odkaz:
https://doaj.org/article/f805c61583564f2b9b8dad71b131c6b7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Best Practice & Research Clinical Rheumatology September 2023 37(3)
Autor:
Vjara Popova, Seraphina Kissling, Raphael Micheroli, René Bräm, Manouk de Hooge, Xenofon Baraliakos, Michael J. Nissen, Burkhard Möller, Pascale Exer, Michael Andor, Oliver Distler, Almut Scherer, Caroline Ospelt, Adrian Ciurea
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-12 (2023)
Abstract Objectives To analyse whether time-varying treatment with tumour necrosis factor inhibitors (TNFi) in radiographic axial spondyloarthritis (r-axSpA) has a differential impact on structural damage progression on different spinal segments (cer
Externí odkaz:
https://doaj.org/article/34d14e5405d840759853d487e881a7a7